IMR Press / RCM / Volume 19 / Issue S1 / DOI: 10.3909/ricm19S1S0005

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Statin Intolerance
Show Less
1 Division of Cardiology, Advocate Heart Institute at Advocate Lutheran General Hospital, Park Ridge, IL
2 Departments of Medicine & Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Rev. Cardiovasc. Med. 2018, 19(S1), 9–19; https://doi.org/10.3909/ricm19S1S0005
Published: 20 January 2018
Abstract
Statins are critical medications to prevent and treat cardiovascular disease2 and they are generally very well tolerated. In some instances, however, statin intolerance may limit use of these lifesaving medications. Statin intolerance has many definitions but is commonly diagnosed when a patient is unable to continue statin therapy due to perceived, or objectively documented, adverse effects. A very high rate of discontinuation of statin therapy warrants a closer look at the implications from the standpoint of cardiovascular risk in statin-intolerant patients, as well as an evaluation of the available options to help patients maintain their statin therapy and understand the potential benefits of such therapy.
Keywords
Statin
Statin intolerance
Statin-associated muscular side effects
Cognitive effects
Diabetes mellitus
Statin discontinuation
Share
Back to top